Bellevue Group Ag Pacific Biosciences Of California, Inc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.52 - $9.59 $9.59 Million - $26.1 Million	-2,724,877 Reduced 37.24%	4,592,251 $17.2 Million
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $429,481 - $745,298	71,940 Added 0.99%	7,317,128 $71.8 Million
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $2.45 Million - $4.15 Million	-297,641 Reduced 3.95%	7,245,188 $60.5 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $5.15 Million - $7.26 Million	516,723 Added 7.35%	7,542,829 $100 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $4.34 Million - $6.58 Million	547,181 Added 8.45%	7,026,106 $81.4 Million
Q4 2022 Feb 14, 2023	BUY	$5.67 - $11.2 $5.89 Million - $11.6 Million	1,039,374 Added 19.11%	6,478,925 $53 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $2.05 Million - $4.47 Million	-521,678 Reduced 8.75%	5,439,551 $31.6 Million
Q2 2022 Aug 11, 2022	BUY	$4.02 - $10.43 $4.34 Million - $11.3 Million	1,079,477 Added 22.11%	5,961,229 $26.3 Million
Q1 2022 May 13, 2022	BUY	$8.43 - $20.9 $28.1 Million - $69.6 Million	3,328,729 Added 214.34%	4,881,752 $44.4 Million
Q4 2021 Feb 10, 2022	SELL	$19.26 - $30.08 $1.74 Million - $2.71 Million	-90,136 Reduced 5.49%	1,553,023 $31.8 Million
Q2 2021 Aug 12, 2021	BUY	$22.3 - $36.02 $572,084 - $924,057	25,654 Added 1.59%	1,643,159 $57.5 Million
Q1 2021 May 12, 2021	SELL	$26.38 - $51.15 $2.13 Million - $4.13 Million	-80,674 Reduced 4.75%	1,617,505 $53.9 Million
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $23.2 Million - $62.9 Million	-2,206,288 Reduced 56.51%	1,698,179 $44.1 Million
Q3 2020 Nov 16, 2020	SELL	$3.61 - $9.87 $16.1 Million - $44 Million	-4,459,274 Reduced 53.32%	3,904,467 $38.5 Million
Q2 2020 Aug 13, 2020	BUY	$2.65 - $4.03 $2.61 Million - $3.97 Million	984,950 Added 13.35%	8,363,741 $28.9 Million
Q1 2020 May 14, 2020	BUY	$2.36 - $5.26 $3.88 Million - $8.65 Million	1,644,482 Added 28.68%	7,378,791 $22.6 Million
Q4 2019 Feb 14, 2020	BUY	$4.6 - $5.57 $15.5 Million - $18.7 Million	3,360,522 Added 141.57%	5,734,309 $29.5 Million
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $11.8 Million - $14.6 Million	2,373,787 New	2,373,787 $12.2 Million
Q4 2018 Feb 12, 2019	SELL	$3.99 - $7.82 $10.3 Million - $20.1 Million	-2,575,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.52 - $5.55 $9.06 Million - $14.3 Million	2,575,000 New	2,575,000 $13.9 Million

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

33.4M
Shares

$65.1 Million
0.54% of portfolio
Black Rock Inc. New York, NY

23.6M
Shares

$46 Million
0.0% of portfolio
Madrone Advisors, LLC Menlo Park, CA

23.4M
Shares

$45.6 Million
6.35% of portfolio
Edmond De Rothschild Holding S.A. Chambesy, V8

20.3M
Shares

$39.6 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

17.6M
Shares

$34.4 Million
0.0% of portfolio

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account